Contributions by role
Contributions by subject area
Sanjay B Rathod
Summary
Sanjay Rathod completed his Ph.D. at the National Institute of Virology, Pune. He worked for Aurigene Discovery Technologies Limited, Bangalore (India), to develop immune-checkpoint and ROR-γt inhibitors to treat cancer/autoimmune diseases before joining the Fernandez lab at the University of Pittsburgh as an International Postdoctoral Associate. His projects involve elucidating the mechanism of asparaginase-induced immune responses, which are among the main drugs used for treating pediatric acute lymphoblastic leukemia, and identifying therapeutic approaches to mitigating the immune response restoring drug efficacy. He has also developed a novel flow cytometry-based assay and validated that simultaneously measures adalimumab and anti-adalimumab antibody concentrations.
Currently, Dr. Rathod's elucidating uses experimental/computational systems approaches to study antigen/epitope discovery in autoimmune disorder, cancer, and SARS-CoV2 infection. He was also looking at the host responses in COVID-19. This work has direct clinical relevance as it can uncover important targets of autoimmune diseases, cancer, and viral infection, especially SARS-CoV2.
Allergy & Clinical Immunology Bioengineering Biotechnology Cell Biology Diabetes & Endocrinology Gastroenterology & Hepatology Genomics Hematology Immunology Infectious Diseases Molecular Biology Oncology Translational Medicine Virology